Effect of dapagliflozin on renal haemodynamics in hyperfiltering T2D patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 944, doi. 10.1111/dom.16094
- By:
- Publication type:
- Article
Works by Hansis‐Diarte, Andrea
Results: 6
1
2
The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 2, p. 139, doi. 10.1007/s00592-017-1065-z
- By:
- Publication type:
- Article
3
Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
- Published in:
- Acta Diabetologica, 2017, v. 54, n. 1, p. 53, doi. 10.1007/s00592-016-0904-7
- By:
- Publication type:
- Article
4
Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.
- Published in:
- 2014
- By:
- Publication type:
- journal article
5
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.
- Published in:
- Diabetes, 2024, v. 73, n. 6, p. 896, doi. 10.2337/db23-0457
- By:
- Publication type:
- Article
6
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. 161, doi. 10.1210/clinem/dgad438
- By:
- Publication type:
- Article